Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) NSE
173.00
-1.97(-1.13%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
173.00
-1.97(-1.13%)
Currency In INR
| Market Cap | 2.56B |
| Enterprise Value | 3.19B |
| P/E Ratio | 0.04 |
| PEG Ratio | 0.1 |
| Price/Sales Ratio | 0.74 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0.88 |
| Enterprise/EBITDA | 7.46 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.11 |
| Return On Assets | 0.04 |
| Return On Equity | 0.07 |
| Revenue | 4.45B |
| Revenue/Share | 39,389.51 |
| Gross Profit | 2.04B |
| EBITDA | 524.39M |
| Net Income | 416.3M |
| Diluted EPS | 20.98 |
| Total Cash | 759.95M |
| Total Cash/Share | 6,725.25 |
| Total Debt | 1.39B |
| Total Debt/Equity | 0.2 |
| Current Ratio | 1.97 |
| Book Value Per Share | 60,217.58 |
| 52-Week Change | -8.47 |
| 52-Week High | 238.69 |
| 52-Week Low | 126.15 |
| Moving Average 50 Days | 161.91 |
| Moving Average 200 Days | 159.23 |
| Average Volume | 47,137 |
| Shares Outstanding | 19M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.16 |
| Payout Ratio | 0.09 |
| Last Split Factor | N/A |
| Last Split Date | N/A |